The pharmaceutical drug promises patients up to a 15% reduction in body mass by slowing digestion and suppressing appetite
Pfizer Acquires a GLP-1 Pipeline and Revives FOMO Corporate Strategy Discussing Pfizer's savvy acquisition of Metsera and critiquing the GLP-1 'gap analysis' many outsiders promote as a reason all the Big Pharmas will be in GLP-1 On Monday, Pfizer PFE 0.00% announced it is acquiring Metsera MTSR 0.00% and its obesity pipeline
The goal is finding your personal maximum effective dosethe level where you achieve meaningful weight loss with side effects you can tolerate, not necessarily reaching 2.4 mg
However, like any medical treatment, some might experience side effects such as nausea, constipation, and diarrhea
Your provider walks through every one of those details before anything is prescribed
These guides walk you through everything from subtle early signs to smart solutionslike when its time to add electrolytes and how to tell if your symptoms might be something more serious